AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
June 07, 2021 07:00 ET
|
AzurRx BioPharma, Inc.
“RESERVOIR” trial to evaluate niclosamide’s ability to target SARS-CoV-2 in the GI tract Topline trial data expected in Q1 2022 BOCA RATON, Fla., June 07, 2021 (GLOBE NEWSWIRE) -- AzurRx...
CEO Presenting on the Emerging Growth Conference on June 9. Register here
June 07, 2021 07:00 ET
|
Emerging Growth
MIAMI, June 07, 2021 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies...
IN8bio Completes Treatment of First Cohort in Phase 1 Clinical Trial with Gamma Delta T-Cell Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme
June 07, 2021 07:00 ET
|
IN8bio, Inc
Single-dose administration of IN8bio’s genetically modified gamma delta T-cells in lymphodepleted glioblastoma multiforme (GBM) patients was well tolerated No observed dose limiting toxicities...
Sophi.io Wins Two INMA Global Media Awards
June 07, 2021 07:00 ET
|
The Globe and Mail
TORONTO, June 07, 2021 (GLOBE NEWSWIRE) -- Sophi.io, The Globe and Mail’s artificial intelligence-powered optimization and prediction platform, was announced as a winner of the International News...
BeyondSpring Announces Three Presentations Highlighting Positive Clinical Outcome Data from the Phase 3 Program of Plinabulin in Combination with Pegfilgrastim for the Prevention of Chemotherapy-Induced Neutropenia at the American Society of Clinical Oncology (ASCO) Annual Meeting
June 07, 2021 07:00 ET
|
BeyondSpring, Inc.
- Data demonstrate that combination of plinabulin and pegfilgrastim offers superior benefit for reducing the incidence and severity of febrile neutropenia (FN) and hospitalization, with better...
Gold Bull Commences 5000m Exploration and Resource Extension Drill Program at Sandman Following on From Phase 1 Success
June 07, 2021 07:00 ET
|
Gold Bull Resources Corp.
VANCOUVER, British Columbia, June 07, 2021 (GLOBE NEWSWIRE) -- Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report that drilling operations will resume this...
Leading Interventional Cardiologist Dr. Giora Weisz Joins Microbot Medical’s Scientific Advisory Board
June 07, 2021 07:00 ET
|
Microbot Medical
HINGHAM, Mass., June 07, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues its ongoing commitment to strengthen and broaden its capabilities as Giora Weisz, MD joined the...
Scorpio Gold Commences Exploration Drilling Program on Manhattan Mine, Nevada
June 07, 2021 07:00 ET
|
Scorpio Gold Corporation
VANCOUVER, British Columbia, June 07, 2021 (GLOBE NEWSWIRE) -- Scorpio Gold Corporation (“Scorpio Gold” or the “Company”) (TSXV: SGN) is pleased to announce the commencement of a 4,800 meter surface...
Ground Magnetic Survey Confirms and Expands Target Areas at Eloro Resources’ Iska Iska Silver-Tin Polymetallic Project, Bolivia
June 07, 2021 07:00 ET
|
Eloro Resources Ltd.
TORONTO, June 07, 2021 (GLOBE NEWSWIRE) -- Eloro Resources Ltd. (TSX-V: ELO; OTCQX: ELRRF FSE: P2QM) (“Eloro”, or the “Company”) is pleased to report results from its recently completely magnetics...
C4 Therapeutics Presents Pre-clinical Data on CFT8919, A Selective Degrader of EGFR L858R, at Keystone Symposium on Targeted Protein Degradation
June 07, 2021 07:00 ET
|
C4 Therapeutics, Inc.
– CFT8919 Induces Tumor Regression in Pre-clinical Models Resistant to First- and Third-generation EGFR Inhibitors – – CFT8919 Demonstrates Intracranial Activity Pre-clinically, Indicating the...